New JAMA COVID-19 Vaccine Study Misses the Mark; Caution Is Needed When Interpreting the Results

The Independent Medical Alliance urges caution on a new JAMA Internal Medicine study linking the 2024-2025 COVID-19 vaccine to reduced cardiovascular events.

0 comments on “New JAMA COVID-19 Vaccine Study Misses the Mark; Caution Is Needed When Interpreting the ResultsAdd yours →

Leave a Reply

Your email address will not be published. Required fields are marked *